Bank Pictet & Cie (Asia) LTD Exact Sciences Corp Transaction History
Bank Pictet & Cie (Asia) LTD
- $1.57 Trillion
- Q2 2024
A detailed history of Bank Pictet & Cie (Asia) LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Bank Pictet & Cie (Asia) LTD holds 47,709 shares of EXAS stock, worth $2.47 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
47,709
Previous 46,946
1.63%
Holding current value
$2.47 Million
Previous $3.24 Billion
37.83%
% of portfolio
0.13%
Previous 0.25%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$924 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$914 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$648 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$625 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$343 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.17B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...